Oncology & Cancer

SCCM: circulating histones for most with thrombocytopenia

(HealthDay)—Most patients with thrombocytopenia have circulating histones, according to a research letter published online Feb. 22 in the Journal of the American Medical Association to coincide with the Society of Critical ...

Oncology & Cancer

Optimal dose suggested for dasatinib in ovarian cancer

(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, according to ...

page 3 from 3